Accelerated UK Clinical Trial Reforms: Enhancin...

By HEOR Staff Writer

November 5, 2025

UK Clinical Trial Reforms Slash Approval Times UK Clinical Trial Reforms have accelerated clinical trial approvals, reducing average times from 91 days to 41 days through risk-proportio...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...
China Medical Research Challenges: Pushing Boundaries Amid Ethical and Qualit...
Medical Schemes Affordability Crisis: Insights from the CMS Annual Report 202...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Aligning Medical Schemes with National Health Insurance South Africa
Obesity Health Economics: Forecasting Trends and Costs in the US
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Evolving Burden of Obesity in the US: Key Insights on Obesity Prevention Stra...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...